Werewolf Therapeutics (HOWL) Insider Trading & Ownership $1.64 -0.03 (-1.80%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Werewolf Therapeutics (NASDAQ:HOWL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.10%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$4.10 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$40,230.00 Get HOWL Insider Trade Alerts Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HOWL Insider Buying and Selling by Quarter Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Werewolf Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2023Ra Capital Management, L.P.DirectorBuy1,853,000$2.21$4,095,130.00 12/15/2021Reid LeonardCOOSell3,000$13.41$40,230.00 (Data available from 1/1/2013 forward) HOWL Insider Trading Activity - Frequently Asked Questions Who is on Werewolf Therapeutics's Insider Roster? The list of insiders at Werewolf Therapeutics includes Ra Capital Management, L.P., and Reid Leonard. Learn more on insiders at HOWL. What percentage of Werewolf Therapeutics stock is owned by insiders? 21.10% of Werewolf Therapeutics stock is owned by insiders. Learn more on HOWL's insider holdings. Which Werewolf Therapeutics insiders have been buying company stock? The following insider purchased HOWL shares in the last 24 months: Ra Capital Management, L.P. ($4,095,130.00). How much insider buying is happening at Werewolf Therapeutics? Insiders have purchased a total of 1,853,000 HOWL shares in the last 24 months for a total of $4,095,130.00 bought. Werewolf Therapeutics Key ExecutivesDr. Daniel J. Hicklin Ph.D. (Age 60)Founder, CEO, President, Secretary & Director Compensation: $928.26kMr. Timothy W. Trost CPA (Age 66)CFO, Treasurer & Assistant Secretary Compensation: $662.99kDr. Randi Isaacs M.D. (Age 68)Chief Medical Officer Compensation: $702.43kDr. Chulani Karunatilake Ph.D. (Age 64)Chief Technology Officer Compensation: $343.43kMs. Ellen A. Lubman M.B.A. (Age 48)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies Adicet Bio Insider Selling Shattuck Labs Insider Selling Xilio Therapeutics Insider Selling Rani Therapeutics Insider Selling Passage Bio Insider Selling Curis Insider Selling Neoleukin Therapeutics Insider Selling Nektar Therapeutics Insider Selling Kodiak Sciences Insider Selling C4 Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:HOWL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.